← Back to headlines




Recursion Pharmaceuticals Considered a Top Penny Stock by Billionaires
Recursion Pharmaceuticals (RXRX) is being evaluated as a leading penny stock, according to the investment preferences of billionaires. The analysis delves into its potential as a high-growth investment.
9 Jul, 17:29 — 9 Jul, 17:29
Sources
Showing 1 of 1 sources
Related Stories

Okta Lifts Full-Year Outlook as Artificial Intelligence Demand Surges
27m ago

Bill Gates Advocates for Human-Reserved Jobs Amid AI Expansion
37m ago

Delayed Cocoa Harvest Risks Port Congestion in Ivory Coast
45m ago

Bank of Korea Implements Consecutive Interest Rate Hikes Signaling Continued Tightening
1h ago